Double-peak elution profile of a monoclonal antibody in cation exchange chromatography is caused by histidine-protonation-based charge variants  by Luo, Haibin et al.
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a  b  s  t  r  a  c  t
We  have  systemically  investigated  unusual  elution  behaviors  of  an  IgG4  (mAb  A)  in cation  exchange
chromatography  (CEX).  This  mAb  A exhibited  two elution  peaks  under  certain  conditions  when  being
puriﬁed  by  several  strong  CEX  columns.  When  either  of  the  two peaks  was  isolated  and re-injected
on  the same  column,  the similar  pattern  was  observed  again  during  elution.  The  protein  distribution
between  the  two peaks  could  be altered by  NaCl  concentration  in  the feed,  or NaCl  concentration  in
wash  buffer,  or  elution  pH,  suggesting  two pH-associated  strong-and-weak  binding  conﬁgurations.  The
protein  distributions  under  different  pH  values  showed  good  correlation  with  protonated/un-protonated
fractions  of a histidine  residue.  These  results  suggest  that the  double-peak  elution  proﬁle  associates
with  histidine-protonation-based  charge  variants.  By  conducting  pepsin  digestion,  amino-acid  speciﬁc
chemical  modiﬁcations,  peptide  mapping,  and  measuring  the  effects  of  elution  residence  time,  a histidineEPC
ydroxylamine
eptide mapping
(ab′)2
in  the  variable  fragment  (Fab)  was  identiﬁed  to  be  the root  cause.  Besides  double-peak  pattern,  mAb  A
can also  exhibit  peak-shouldering  or  single  elution  peak  on different  CEX  resins,  reﬂecting  different
resins’  resolving  capability  on protonated/un-protonated  forms.  This  work  characterizes  a  novel cause
for unusual  elution  behaviors  in CEX  and  also  provides  alternative  avenues  of  puriﬁcation  development
for  mAbs  with  similar  behaviors.
©  2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Cation exchange chromatography (CEX) is well established as
n important tool for puriﬁcation of monoclonal antibodies (mAbs)
1], however, its utility is sometimes inﬂuenced by protein chemical
eatures that create unexpected results [2]. For example, resin-
rotein interactions resulted in conformational changes on an IgG1
hat led to two elution peaks in Fractogel SO3-(M)  CEX chromatog-
aphy with unfolded proteins contributing to the late eluting peak
3–6]. Our previous work reported salt-induced reversible self-
ssociation of an IgG2 resulted in two elution peaks in multiple
ation exchangers [7]. Zhang et al. reported a mAb  that demon-
trated strong retention on CEX due to a highly concentrated charge
atch in the variable domain [8]. In addition to mAbs, human serum
∗ Corresponding author. Tel.: +1 301 398 4845.
E-mail address: Liyu@Medimmune.com (Y. Li).
ttp://dx.doi.org/10.1016/j.chroma.2015.11.008
021-9673/© 2015 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
albumin was also reported to exhibit peak-splitting on CEX due to
two binding conﬁgurations [9,10].
Among the 20 amino acids, histidine is the third least frequently
occurring amino acid in proteins, but because of the near-neutral
pKa of its imidazole group, histidine is involved in many biological
functions [11,12]. Histidine can be either protonated (charged) or
un-protonated (neutral) depending on the solution pH. Histidine
has been found to be in the active sites of many enzymes [13], pH
sensors for viruses’ fusions into host cells [14] and pH switch con-
trolling “open” and “close” status of ion channels [15]. The averaged
pKa for a histidine residue is pH 6.0, but the actual pKa of a histi-
dine residue depends on its surrounding environment. Histidine
residues in a hydrophobic environment usually have a more acidic
pKa (down shifted) and likely a slow protonation rate as well [16].
Diethyl pyrocarbonate (DEPC) speciﬁcally modiﬁes solvent
accessible (protein surface), un-protonated histidine residues. The
DEPC modiﬁcation can be reversibly removed by hydroxylamine.
This highly speciﬁc and reversible chemical modiﬁcation has
become a valuable tool to study the role of histidine residue. In
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ddition, DPEC modiﬁed histidine residues can be used to map  out
heir precise location using mass spectrometry [12,17].
In the present work, we have systematically investigated the
ouble-peak behaviors of a mAb  A and identiﬁed the root cause to
e a histidine protonation based charge variants with the histidine
ocating in its variable heavy chain domain.
. Materials and methods
.1. Chemicals, recombinant protein and cation exchanger resins
All the chemicals used in this study were obtained from J.T.
aker (Phillipsburg, NJ, USA). Buffers and cleaning solutions were
repared in house. The mAb  A was expressed in Chinese hamster
vary (CHO) cells and produced by MedImmune LLC (Gaithers-
urg, MD,  USA). It is a fully human monoclonal antibody (IgG4)
omposed of two identical heavy chains and two  identical light
hains, with an overall molecular weight of 148 kDa. The theoreti-
al isoelectric point is 7.4. Unless noted otherwise, the protein feed
aterial was puriﬁed using a Protein A afﬁnity column and has
urity of 98.5% monomer. POROS HS50 resins were from Applied
ioSystems (Grand Island, NY, USA); Fractogel EMD  SO3-(M)  resins
ere from EMD  Biosciences (Gibbstown, NJ, USA); Eshmuno CPX
esins were from EMD  Millipore (Billerica, MA,  USA); CIMmultus
O3- column was from BIA Separations (Wilmington, DE, USA);
uvia S resins were from Bio-Rad (Hercules, CA, USA), SP Sepharose
ast Flow, Source 30S, and MabSelect Sure (MSS) protein A resins
ere from GE Healthcare (Piscataway, NJ, USA); Toyopearl SP 650M
esins were from Tosoh Bioscience (King of Prussia, PA, USA). The
ndoproteinase Lys-C was purchased from Promega (Madison, WI,
SA).
.2. Chromatography instrumentation and operations
Laboratory scale chromatographic experiments were carried
ut on a GE Healthcare ÄKTA Explorer 100 controlled by Uni-
orn software version 6.4 (GE Healthcare, Piscataway, NY, USA).
esides CIMmultus SO3- (commerically available as prepacked col-
mn), the CEX resins was packed into 0.66 cm inner diameter (ID)
mniﬁt® columns (Diba Industries, Danbury, CT, USA) to a bed
eight of 19 ± 3 cm.  Unless mentioned otherwise, the CEX columns
ere operated under the following conditions: 3 CV (column vol-
me) the Equilibration buffer (50 mM sodium acetate, pH 5.0) for
re-loading equilibration; loading under pH 5.0 using 5 mg/mL
esin as load challenge; 3 CV Wash buffer after loading; followed
y 20 CV 0–500 mM NaCl linear gradient elution (LGE) at pH 5.0
buffered by 50 mM NaAc); 3 CV of 50 mM Tris–HCl, pH 7.0, 1 M
aCl for strip; 3 CV 0.1 M NaOH for sanitation; 3 CV 20% ethanol
or column storage; all steps used 5 min  as residence time. The
bsorbance of the protein was monitored at A280 by the built-in
KTA probe. The elution was fractionated in one CV fraction based
n A280 collection criteria of ≥50 mAu. In-line pH and conductivity
ere also monitored for all test runs. Unless mentioned otherwise,
hromatographic experiments were carried out at room tempera-
ure. Protein concentration was measured using a NanoDrop 2000
Thermo Fisher Scientiﬁc, Wilmington, DE. USA). In the experiment
f re-purifying the ﬁrst and second peak proteins from the Poros
S50 chromatography, the collected pools were buffer exchanged
nto 50 mM sodium acetate pH 5.0 prior to loading. In the experi-
ents of obtaining elution proﬁle for different pH values, pH levels
rom 4.0 to 5.5 were provided by 50 mM NaAc and pH levels from
.5 to 6.5 were provided by 50 mM sodium phosphate, respectively.
n the experiments testing temperature effect on elution proﬁle,
he POROS HS50 resins were packed in a jacketed column with
he temperature controlled by PolyScience circulating water bath 1424 (2015) 92–101 93
(Burlington, VT, USA). In the POROS HS50 puriﬁcation of the DEPC
modiﬁed and hydroxylamine reversed samples, all samples were
quenched by adding 6 mM imidazole before loading and 4 mg load
mass were used.
2.3. Analytical size-exclusion chromatography (HP-SEC)
Purity analysis was  performed using a TSK-GEL G3000SWXL col-
umn  (7.8 mm × 30 cm)  from Tosoh Bioscience (King of Prussia, PA,
USA) with an Agilent HPLC system HP1200 from Agilent Technolo-
gies (Santa Clara, CA, USA). The column was equilibrated at a ﬂow
rate of 0.5 mL/min with 78 mM  sodium phosphate, 0.5 M sodium
chloride, pH 7.4. All collected fractions were injected and eluted
isocratically with the same buffer. The eluted protein was  moni-
tored by UV absorbance at 280 nm.  Samples were 0.22 m ﬁltered
and injected at a mass load of 0.25 mg.  All injected volumes were
less than 0.7% of the column volume. The monomer, dimer, and
aggregate were estimated by integrating the chromatograms.
2.4. Diethyl pyrocarbonate (DEPC) modiﬁcation and reversal by
hydroxylamine
DEPC was purchased from Sigma–Aldrich (St. Louis, MI,  USA)
and stored desiccated at 4 ◦C to minimize decomposition by hydrol-
ysis. DEPC stock solution was freshly prepared by diluting 100%
DEPC solution with cold absolute ethanol at a ratio of 1:19 (v/v).
DEPC modiﬁcation to mAb  A histidine residues was  initiated by
adding the DEPC stock solution to mAb  A (at 1 mg/mL) in 50 mM
NaAc, pH 5.0. A low ratio of 2.5 L DEPC stock versus 1 mL of pro-
tein solution was used to make the ﬁnal DEPC concentration to be
around 1 mM.  The reaction temperature was controlled by incu-
bation in a 25 ◦C water bath. The reaction process was  monitored
by measuring UV242 on 8453 UV dissolution systems from Agilent
Technologies (Santa Clara, CA, USA). In the experiments showed in
Fig. 4, 4 mL  samples (1), (2) and (3) were taken at 0, 10 and 20 min
after DEPC modiﬁcation started. Each sample was added 40 L of
300 mM imidazole (pH 5.0) stock to quench the unreacted DEPC.
The samples were conditioned and then subjected to puriﬁcation
by the POROS HS50 column. The removal of DEPC modiﬁcation was
performed by adding hydroxylamine at a ratio of 10 L 2 M hydrox-
ylamine (pH 5.2) per 1 mL  protein solution. 4 mL  samples (4) and
(5) were taken at 20 and 40 min  after hydroxylamine addition. In
experiments showed in Fig. 7A, a ratio of 17 L DEPC stock per 1 mL
protein solution was used get 6 mM DEPC ﬁnal concentration. The
reaction was allowed for 30 min  until the UV242 signal reached a
plateau. The modiﬁed sample was  puriﬁed on POROS HS50. The
major peak was  collected and analyzed by mass spectrometry pep-
tide mapping.
2.5. Far-UV circular dichroic (CD) and ﬂuorescence spectroscopy
Far-UV CD measurements were performed on a Jasco-815
instrument (Easton, MD,  USA). The native and modiﬁed mAb A
proteins were prepared in 50 mM NaAc pH 5.0 and analyzed in a
0.1 cm pathlength cuvette (1-Q10, Starna, Atascadero, CA). Spec-
tra were collected at standard sensitivity range (100 mdeg) with
0.5 nm data pitch, 10 nm/min scanning rate, and 8 s integration time
in the range from 200 to 250 nm.  Five replicates were averaged for
each sample.
8-Anilino-1-naphthalenesulfonic acid (ANS) was from
Sigma–Aldrich (St. Louis, MI,  USA). In the ANS binding exper-
iments, mAb  A was prepared at 0.4 mg/mL  in the corresponding
buffers. A 1.2 mM  ANS stock solution was added to each sample to
a ﬁnal concentration of 120 M and ANS binding was allowed for
2 h in dark at ambient temperature. The ﬂuorescence signal of each
sample was  measured by Spectra Max  M2  (Molecular Devices,
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Fig. 1. mAb  A demonstrated double-peak elution pattern in POROS HS50 during linear gradient elution. (A) Elution proﬁle of mAb  A over a 20 CV linear elution gradient
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raction. (B) Separate re-puriﬁcation of the proteins from each peak led to simila
hallenge was achieved by changing injection volume. The equilibration and elutio
unnyvale, CA, USA). The excitation wavelength was  360 nm,  and
mission was monitored at 500 nm.  For the intrinsic ﬂuorescence
easurement, the samples at 0.4 mg/mL  concentration were
repared in the corresponding buffers then measured by EnVision
late Readers (Perkin Elmer, Waltham, MA,  USA). The excitation
avelength was 280 nm,  and emission was monitored at 338 nm.
he buffers used in Fig. 5D were made by titrating 50 mM NaAc pH
.5 with 50 mM sodium phosphate pH 6.5. All experiments were
un in triplicate.
.6. Preparation of F(ab’)2 domain of mAb A using pepsin
igestion
The agarose immobilized pepsin was purchased from
igma–Aldrich (St. Louis, MO,  USA). mAb  A was  digested by
epsin-agarose (1 mg  pepsin-agarose dry powder per 6 mg  mAb  A)
t pH 4.0 in a 37 ◦C water bath for overnight. The digested product
as adjusted to pH 7.0 and then was puriﬁed by ﬂowing through a
abSelectSure (MSS) column pre-equilibrated at pH 7.0. The intact
Ab  A and Fc domains were retained on the MSS  column. The ﬂow
hrough was collected and was further puriﬁed by Toyopearl SP
50M to show a single F(ab′)2 peak on HP-SEC.
.7. Peptide mapping with Mass Spectrometry
The sample was denatured by 6 M guanidine hydrochloride
Sigma–Aldrich, St. Louis, MI,  USA) in 50 mM phosphate buffer, pH
.0 at 37 ◦C for 30 min. After denaturation, the sample was  diluted
.5-fold with 100 mM phosphate buffer containing 0.06 mM EDTA
t pH 7.0. Lys-C was added at a 1:10 Lys-C: protein ratio and the
eaction mixture was incubated at 37 ◦C for 16 h. In order to getack solid line represents the A280 trace. The solid squares represent purity of each
ble-peak pattern. (C) Elution proﬁles for different load challenges. Different load
er used 50 mM NaAc, pH 5.0 as the buffer system for above runs.
complete digestion, additional Lys-C was  added at the same ratio
and further incubated for a 4 h at 37 ◦C. Following Lys-C digestion,
sample was reduced with DTT at 37 ◦C for 15 min. The digested
peptides were separated by a reverse phase Zorbax C18 column on
Waters UPLC (Milford, MA,  USA) followed by analysis using a UV
detector and an on-line Fusion mass spectrometer from Thermo
Fisher scientiﬁc (Waltham, USA). The RP-UPLC mobile phase A was
0.02% TFA in water and the mobile phase B was 0.02% TFA in
acetonitrile. The histidine modiﬁcation levels were calculated by
integrating the modiﬁed and un-modiﬁed peak areas of selected
ion chromatograms from the ESI-MS (electrospray ionization mass
spectrometry).
3. Results and discussion
3.1. Highly puriﬁed mAb A exhibits double-peak elution behavior
in POROS HS50
As shown in Fig. 1A, a highly puriﬁed mAb A exhibits double-
peak pattern of the anticipated major peak in POROS HS50 (strong
CEX) during salt linear gradient elution. Both peaks contained
mainly pure mAb  A proteins, determining by HP-SEC analysis.
When isolated and re-injected on the column under the same
conditions, the proteins from each peak reformed similar elution
pattern (Fig. 1B). Additional puriﬁcations of peak fractions resulted
in the same elution proﬁle (data not shown), suggesting inter-
change of the proteins in the two  peaks. No signiﬁcant difference
was detected on the proteins from the two  peaks by biophysical
analyses such as isoelectric focusing, mass spectrometry, dynamic
light scattering and differential calorimetry scanning (data not
shown). The elution pattern was observed to remain similar
H. Luo et al. / J. Chromatogr. A 1424 (2015) 92–101 95
Fig. 2. mAb A may  have two binding conﬁgurations to POROS HS50 resins. (A)
Effects of 100 and 80 mM NaCl salt wash on elution proﬁle for mAb  A. Salt con-
centration was  gradually increased to and maintained at the desired level for 6 CV.
3  CV equilibration was applied before the linear salt gradient elution. (B) Effects of
the presence of 100 mM NaCl and ArgHCl during load on elution proﬁle. Equilibra-
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Fig. 3. The double-peak pattern of mAb  A may be associated with a histidine residue.
(A) Elution proﬁles for mAb A in POROS HS50 under pH 4.7, pH 5.0, pH 5.2 and
ﬁrst peak was equal to the gain on the second peak, suggesting theion buffer matched the load was applied before loading. All runs were operated at
H 5.0 and using 5 mg/mL  load challenge.
egardless of different loading (1–20 mg/mL) changes (Fig. 1C).
herefore, load challenge does not play a role. We  previously found
alt-induced reversible self-association resulted in peak-splitting
f an IgG2 in several strong CEX resins [7]. However, reversible
elf-association was not detected for mAb  A under the CEX condi-
ions tested using several analytical techniques (data not shown).
uo and Carta recently reported that an IgG1 exhibited two  elution
eaks following a 1000 min  hold on the CEX column after loading
3–5]. They found the late eluting peak contained aggregates and
as due to resin mediated protein unfolding. For mAb  A, no signif-
cant aggregation was found during the POROS HS50 puriﬁcation
uggesting that on-column aggregation is not a likely cause.
.2. Two  different binding conﬁgurations with weak and strong
nteractions are the most likely cause of the ﬁrst and second
lution peak respectivelyVitol et al. reported that human serum albumin (HSA) showed
wo elution peaks that represent weak and strong binding con-
gurations [9,10]. In order to test whether mAb  A double-peakpH  5.4. (B) The peak sizes overlapped well with theoretical neutral and proto-
nated fractions at different pH values. The theoretical curves were plotted using
Henderson-Hasselbalch equation with an assumptive pKa of pH 5.3.
phenomena follows a similar mechanism, two  sets of experiments
were carried out.
In the ﬁrst set of experiments (Fig. 2A), after mAb A was  bound
on the POROS HS50 column, a wash with 100 mM NaCl (the salt
concentration for eluting peak 1 in Fig. 1A) was applied prior to the
linear gradient elution. As expected, this 100 mM NaCl wash eluted
some proteins off the column. The 100 mM NaCl wash seemed to
preferentially elute the proteins in the ﬁrst peak while the second
peak remained similar to that of the control run. When the salt con-
centration in the wash was decreased to 80 mM NaCl, no protein
was eluted from the column. However, the ﬁrst peak became very
small and the second elution peak became proportionally larger,
compared to the control run. These results support the hypothesis
that mAb  A has two  binding conﬁgurations on POROS HS50. Pro-
teins bound through the weak binding conﬁguration were eluted
by a NaCl concentration of 80 mM,  but they could re-bind to the
resins through the strong binding conﬁguration.
In the second set of experiments (Fig. 2B), binding of mAb  A to
the column occurred in the absence or presence of 100 mM NaCl.
The presence of 100 mM NaCl during loading resulted in smaller
peak 1 and larger peak 2. Compared to the control run (mAb A
binding happened in the absence of 100 mM NaCl), the loss on thepresence of 100 mM NaCl made mAb  A adapt the strong binding
conﬁguration. These data further supported our hypothesis that
the ﬁrst and second peak represents the weak and strong binding
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Fig. 4. The double-peak pattern is associated with a histidine residue on protein surface. (A) Reaction schematic for DEPC chemical modiﬁcation on histidine residue and
hydroxylamine removal of DEPC modiﬁcation. DEPC modiﬁes the imidazole side group of neutral surface histidine to produce N-carboethoxyhistidine. N-Carboethoxyhistidine
can  be reversed to Histidine by hydroxylamine. N-Carboethoxyhistidine has characteristic UV242 absorbance. (B) UV242 absorbance of 1 mg/mL mAb  A sample (in 50 mM NaAc,
pH  5.0) that was  modiﬁed by DEPC for 20 min  then the modiﬁcation was  reversed by hydroxylamine for 40 min. The reactions were carried out at ambient room temperature.
The  sample was measured by UV spectrum on 1 min  interval basis. (C) Elution proﬁles in POROS HS50 for DEPC modiﬁed samples and hydroxylamine reversed samples.
Samples (1), (2), and (3) was  mAb  A modiﬁed by DEPC for 0, 10 and 20 min, respectively; while samples (4) and (5) was DEPC modiﬁed mAb  A reversed by hydroxylamine
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wor  20 and 40 min, respectively. 4 mg  sample was loaded in each POROS HS50 run. (
onﬁgurations, respectively. mAb  A can freely bind on the POROS
S50 reins by both conﬁgurations when there was no salt present
uring loading. When the weak binding conﬁguration was not
avorable (such as 100 mM NaCl was present), most mAb  A proteins
ind to the column through the strong binding conﬁguration.
Additionally, the presence of 100 mM arginine hydrochloride
ArgHCl) showed similar effects to 100 mM NaCl. ArgHCl has been
eported to efﬁciently weaken resin-protein binding mediated
nfolding and therefore decreased the second elution peak in the
ase for the aforementioned unstable IgG1 [7,8]. In this case, ArgHCl
howed opposite effects for mAb  A, i.e. it enlarged the second peak.
hese results further ruled out the possibility of resin mediated
nfolding/aggregation for mAb  A’s double-peak pattern.
.3. Protein distribution is modulated by elution pH and when
lotted against pH ﬁts to the Henderson-Hasselbalch equation
ith a pKa of 5.3
To evaluate whether pH value impacts on mAb  A’s adaption
f the two binding conﬁgurations in POROS HS50, puriﬁcation
f mAb  A was performed under a series of pH conditions (pH
.3–6.5) using the same linear salt gradient elution. The double-
eak phenomenon was observed in all tested runs (Fig. 3A) but
as variable in extent. The ratio of the two peaks showed high spectra for native and DEPC modiﬁed mAb  A.
dependence on the operating pH condition. Higher pH value
resulted in larger early-eluting peak but smaller late-eluting peak
while low pH conditions favored the late elution peak. At pH 4.6,
the late-eluting peak dominated; at pH 5.0, the late-eluting peak
still dominated but the early-eluting peak became larger; at pH
5.2, two peaks were roughly equal in size; at pH 5.4 and pH 5.8,
the early-eluting peak became dominant. This trend was more
obvious in the plotting of peak percentage against the operating
pH values (Fig. 3B). The resulting data can be ﬁtted into Henderson
Hasslbalch equation that describes the pronation/de-protonation
of a charge group. The ﬁtted pKa is about pH 5.3. The curve for the
ﬁrst peak percentage resembled the deprotonation curve while
the second peak resembles the protonation curve.
Among the charged groups in mAb  A, histidine residue is a pro-
ton accepting amino acid with a pKa of pH 6.0. pH 6.0 is actually
an averaged value and pKa value of a histidine residue has been
found to range from pH 4.5 to 7.5, depending on its surrounding
environment [16]. A histidine residue is positively charged when
it is in a protonated state and neutral in un-protonated state. Pro-
tein isoforms with 1+ charge difference, such as native mAb and
its deamidated forms (on asparagine), are known to cause several
elution peaks on CEX [18]. Based on these, we hypothesized that
a histidine residue is associated with the double-peak pattern of
mAb  A.
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Fig. 5. The double-peak causing histidine in mAb  A has slow rate of protonation. (A) mAb A elution proﬁles in POROS HS50 for different elution ﬂow rates. Only the elution
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 mg/mL and 0.5 mg/mL  load challenge. The peak 1 percentage was  calculated from 
esidence time for different operating temperatures. (D) ANS binding and intrinsic
.4  mg/mL.
.4. Solvent accessible histidine with a pKa of 5.3 is the most
ikely cause of the double-peak pattern of mAb A
We  attempted to test the histidine hypothesis through a series
hemical modiﬁcations that were targeted at solvent accessible
istidine residues and measuring the effect on the double-peak
henomenon. Diethyl pyrocarbonate (DEPC) speciﬁcally modiﬁes
istidine residues on protein surfaces at concentrations less than
0 mM [12]. As shown in Fig. 4A, DEPC modiﬁes neutral histidine
esidues to give the modiﬁed product N-carboethoxyhistidine; this
roduct can be reversed back to histidine by hydroxylamine. N-
arboethoxyhistidine also has characteristic absorbance at UV242
llowing the modiﬁcation and reversal reactions to be monitored
y following UV242 absorbance.
Many published studies established that DEPC only modiﬁes
istidine residue in un-protonated (neutral) state [12]. Neutral pH
s usually used to maximize modiﬁcation because most histidine
esidues are in the un-protonated state at neutral pH. However, we
elected an acidic pH for the DEPC modiﬁcation for mAb A to selec-
ively modify histidines with a pKa value near pH 5.3 and reduce
odiﬁcation on other histidine residues that have a more standard
igher pKa.
As shown in Fig. 4B, after 1 mM DEPC was added to mAb  A pro-
ein solution, UV242 signal of the reaction mixture increased quickly
ver time, indicating the quick production of the DEPC modiﬁed
istidine product. After 10 mM hydroxylamine was  added to the
eaction mixture, the UV242 signal decreased with time, indicating
he reversal of N-carboethoxyhistidine back to histidine. The rever-
al of N-carboethoxyhistidine by hydroxylamine was  slower than
EPC modiﬁcation, consistent with the published reports [17].me. (B) The plotting of the ﬁrst elution peak percentage against residence time for
n peak area integration. (C) The plotting of the ﬁrst elution peak percentage against
scence data under different pH values. mAb A concentration in these samples are
Five samples were taken at different time points indicated in
Fig. 4B. Imidazole was  added to each sample to quench the unre-
acted DEPC before these samples were run in the POROS HS50
column (Fig. 4C). Compared to the control sample, the 5-min mod-
iﬁed sample exhibited larger early elution peak and smaller late
eluting peak; the 10-min modiﬁed sample had dominant early
eluting peak and the late eluting peak became very small. On  the
contrary, double-peak reappeared on the hydroxylamine-reversed
samples. Additionally, the DEPC modiﬁed and native mAb  A were
also analyzed by far-UV CD (Fig. 4D). Their similar CD spectra indi-
cate that DEPC modiﬁcation on mAb  A resulted in no signiﬁcant
changes on the overall structure, consistent with the published
reports [17].
These results suggested that the double-peak pattern of mAb  A
in POROS HS50 is associated with histidine residue on the protein
surface. Its un-protonated and protonated states correlate with the
early eluting peak (the weak binding conﬁguration) and late eluting
peak (the strong binding conﬁguration), respectively.
3.5. The low pKa histidine has a slow protonation rate
Protonation and deprotonation of solvent accessible residues
is a typically dynamic in nature, with rapid interchange occur-
ring between the two forms to reach equilibrium. When proteins
bound in weak binding conﬁguration (the histidine residue is in un-
protonated state) were eluted off the resins and entered the mobile
phase, the histidine residue on some proteins should protonate to
maintain the equilibrium in the mobile phase. The proteins with
the newly protonated histidine should be able to re-bind to the
9 togr. A 1424 (2015) 92–101
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Fig. 6. The histidine residue is from the variable domain of mAb  A. (A) Schematic
illustration of histidine residues in mAb  A. 8 histidine residues in the heavy chain
and 2 in the light chain. (B) The puriﬁed F(ab′)2 of mAb A exhibited two elution peaks8 H. Luo et al. / J. Chroma
esins. If the protonation is sufﬁciently fast, all of the early eluting
roteins should protonate and bind back to column before going
ut of the POROS HS50 column, and then the ﬁrst peak will not be
bserved. Why  then, did mAb  A show the ﬁrst peak? One explana-
ion is that the protonation of mAb  A is slow and the timescale of
nterchange between the two forms is on the time scale of separa-
ion for the HS50 column. If this is the case, elution residence time
hould demonstrate signiﬁcant impact on the double-peak pattern.
In order to test this hypothesis, the elution ﬂow rate was  var-
ed to achieve different residence time while other conditions
emained the same. As shown in Fig. 5A, elution residence time
id show a signiﬁcant impact. The ﬁrst peak decreased and the
econd peak increased if a longer residence time was  used. When
.3 min  was used as the elution residence time, the ﬁrst and second
eaks are equally large; when prolonged residence time of 30 min
as used, the ﬁrst peak became much smaller and the second peak
ecame dominant. Fig. 5B showed the plotting of the sizes for the
arly eluting peak again the elution residence times. Obviously,
onger residence leads to smaller early eluting peak. One may  argue
hat binding capacity is lower at higher ﬂow rate and the rebinding
an be limited by binding capacity instead of protonation rate. This
ossibility was ruled out because similar results were obtained for 5
nd 0.5 mg/mL  binding capacities (Fig. 5B). Diffusive mass transport
f mAb  A inside the POROS HS50 beads seems contribute slightly
o the slow conversion because such conversion on monolithic CEX
olumn (CIMmultus SO3-) was 2 times faster (data not shown).
ore study is underway to understand the differences between
he two columns. Although the conversion on the above mono-
ithic CEX column is faster, a complete conversion still took more
han 10 min. Therefore, these results suggested the double-peak
ausing histidine residue in mAb  A has slow protonating rate.
We also found that operating temperature has signiﬁcant
mpacts on the double-peak pattern (Fig. 5). Protein diffusion
s usually slower at lower temperatures. If this is the case, the
rst peak should be smaller at low temperature when using
he same residence time. However, Fig. 5C showed the opposite
esults, suggesting slower protonation under lower temperature.
his is consistent with the published results about temperature
ependence of histidine protonation [19]. Although it can be
ffected by factor like temperature, the conversion rate between
he un-protonated and protonated states is typically fast and
n less-than-a-second scale [20]. Protonation-coupled protein
onformational transitions are ubiquitous in biology, such as pro-
ein folding, unfolding, and catalysis [21]. Slow conformational
hanges are found to be associated with slow histidine proto-
ation/deprotonation [21]. We  hypothesized that conformational
hange may  couple with the protonation/de-protonation of this
istidine.
Conformational changes at pH values around the pKa of pH 5.3
ere probed by extrinsic (ANS) and intrinsic ﬂuorescence mea-
urements. Both the ANS and intrinsic ﬂuorescence data suggested
mall conformational changes when pH value altered from pH 6.5
o pH 4.5. Speciﬁcally, mAb  A surface hydrophobicity (open squares
n Fig. 5D) slightly increased with decreasing pH values. While
ossible, we cannot be certain whether the observed conforma-
ional changes are associated with protonation/deprotonation of
he histidine and further study would be needed to demonstrate
his conclusively.
.6. Mapping of the histidine residue in mAb  A’s primary sequence
uggest a rationale for the low pKa and slow protonation rateIn the primary protein sequence of mAb  A, the heavy and light
hain has 8 and 2 histidine residues, respectively. As shown in
ig. 6A, ﬁve histidine residues (#1–5) are in the F(ab′)2 domain and
ve (#6–10) are in the Fc domain. However, only the #1 histidine ison POROS HS50 during 0–500 mM NaCl LGE. The inlet shows the HP-SEC proﬁle of
the puriﬁed F(ab′)2. The preparation of the puriﬁed F(ab′)2 was described in the
Materials and Methods section.
in the variable domain while the other 9 histidine residues (#2–10)
are in constant domains. Most mAbs have these 9 histidine residues
in their primary sequence but they don’t usually exhibit double-
peak pattern in cation exchanger chromatography. Therefore, we
hypothesized that #1 histidine was responsible for the double-peak
pattern.
To test this, the F(ab′)2 from mAb  A was  generated by pepsin
digestion, puriﬁed, and then tested on POROS HS50 (Fig. 6B). Like
mAb  A, the puriﬁed F(ab′)2 also exhibited a similar elution proﬁle,
supporting the #1 histidine hypothesis but this did not rule out the
involvement of #2–5 histidine residues.
Peptide mapping has been used to successfully identify DEPC
modiﬁed histidine residues on variety of proteins [17,22]. There-
fore, we  further used peptide mapping to identify the double-peak
causing histidine residue. In order to produce homogenously mod-
iﬁed sample for peptide mapping, the DEPC modiﬁcation reaction
was performed at pH 5.0 and prolonged to reach an UV242 plateau
(the inset of Fig. 7A). This DEPC modiﬁed mAb A exhibited a dom-
inant elution peak on POROS HS50 (Fig. 7A), indicating a complete
DEPC modiﬁcation on the expected histidine residue. The modiﬁed
sample was  analyzed by LC-MS peptide mapping and the native
mAb  A sample was used as a control. Peak differences in UV proﬁles
of these two samples were found to be mainly related to modiﬁ-
cation on histidine residues. Several peptides showed signiﬁcant
differences (Fig. 7B): the peptides labeled as P1-P6 are the pep-
tides containing histidine residue (from the native mAb  A sample);
while the peptides P1′–P6′ contain modiﬁed histidine residue (from
the DEPC modiﬁed mAb  A sample). The modiﬁed histidine residues
were identiﬁed by comparing the MS/MS  spectra of the correspond-
ing native and modiﬁed peptides. Fig. 7C and D demonstrated the
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Fig. 7. Identiﬁcation of the histidine residue by MS  peptide mapping. (A) Generation of homogenous sample for peptide mapping by allowing complete reaction and further
enrichment by POROS HS50. The inlet is the UV242 absorbance for 1 mg/mL  mAb  A modiﬁed by 6 mM DEPC at room temperature for 30 min. The UV242 reached a plateau at
25  min. (B) Mirror image of LC chromatograms (UV) from the native and DEPC modiﬁed mAb  A. Compare to the native sample, the DEPC modiﬁed sample exhibited some
new  peptides (P1′–P6′) resulted by DEPC modiﬁcation on histidine residue(s). (C) MS/MS  of the peptide with the #1 histidine residue from native mAb  A. (D) MS/MS  of the
peptide with the modiﬁed #1 histidine residue from the DEPC modiﬁed mAb A. The fragment ions Y10, Y23, Y24, and Y28 are from the DEPC group on DEPC modiﬁed #1
histidine. These ions were not seen in the native mAbA.
100 H. Luo et al. / J. Chromatogr. A 1424 (2015) 92–101
Table 1
Modiﬁcation levels of mAb A histidine residues determined by MS  peptide mapping.
Histidine residue Location Modiﬁcation (%)a Primary sequence contextb
#1 F(ab′)2 VH CDR 94.5 H
#2 F(ab′)2 CH1 78.8 ⊕ H
#3 F(ab′)2 CH1 9.7 ⊕H⊕
#4 F(ab′)2 CL 26.8 ⊕⊕H⊕
#5 F(ab′)2 CL 54.6 ⊕H⊕
#6 FC CH2 40.1 ⊕ H⊕
#7 FC CH2 14.9 H⊕⊕
#8  FC CH3 21.0 H⊕
#9 FC CH3 23.8 H⊕⊕
#10 FC CH3 9.4 ⊕⊕H⊕⊕
a The modiﬁcation of all histidine’s calculated by the modiﬁed and unmodiﬁed peak area using selected ion chromatograms from ESI-MS detection peaks eluting from
HPLC  separation of Lys C fragments containing histidine.
b The symbol “ ” represents non-polar residue (I, F, V, L, W,  M,  A, G, and P) and the symbol “⊕” represents polar and charged residue (D, E, K, R, N, Q,  S, T, H, Y, and C).
Fig. 8. Elution proﬁles of mAb  A in different strong CEX resins. The evaluated resins were packed in 0.66 cm column with similar height. CIMmultus SO3- column is a
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tre-packed column. Load challenge was 5 mg/mL  resin. The equilibration and elut
houldered peaks.
dentiﬁcation of the modiﬁed #1 histidine residues. The fragment
ons Y10, Y23, Y24, and Y28 in Fig. 7D revealed the modiﬁcation on
he #1 histidine residue. Modiﬁcation levels were calculated using
he corresponding selected ion chromatograms from ESI-MS detec-
ion and the results were summarized in Table 1. The #1 histidine
esidue in one of the CDRs (complementary determining regions) in
he heavy chain had the highest modiﬁcation level of 94.5%. Another
istidine residue (#2) from the F(ab′)2 domain, also had high mod-
ﬁcation level of 78.8%. The rest of the histidine residues (#3–10)
ad much lower modiﬁcation levels and thus were ruled out.
The combination of the two experimental methods used to map
ut the precise histidine responsible for double-peak pattern sup-
ort the #1 histidine hypothesis and ruled out all other possible
istidine residues except for the #2 histidine. We  argue that the #1
istidine residue is the more likely residue because it is surrounded
y 4 hydrophobic residues in primary structure, consistent with
ts estimated acidic pKa (pH 5.3) and slow protonation rate. Fur-
hermore, the #2 histidine is located in the constant domain andffer used 50 mM NaAc, pH 5.0 as the buffer system. The black arrows indicate the
thus commonly occurring in other mAbs that do not all display the
double-peak pattern.
3.7. The amount of dual-binding can be modulated by the CEX
resins used to purify mAb A
Several CEX resins were tested to see how they resolved the
protonated/un-protonated forms. As showed in Fig. 8, mAb  A
showed double-peak pattern in POROS HS50, Fractogel SO3-(M),
Eshmuno CPX and even on monolithic CIMmultus SO3- columns;
peak-shouldering on Nuvia S, Source 30S, and Sepharose SP FF
columns; but a singular peak on Toyopearl SP 650M column. We
believe that these results reﬂect the resolutions of different CEX
resins on the protonated and un-protonated forms. The results sug-
gest resin screening may  offer a relatively quick solution to the slow
rate of histidine protonation caused double-peak pattern, but this
solution likely result in a process removing many of the efﬁciencies
that go along with better behaved mAbs.
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. Conclusion
In this work, we systematically investigated an unusual CEX elu-
ion proﬁle of mAb  A. The early and late elution peaks correlate with
he un-protonated (neutral) and protonated (charged) states of the
istidine, respectively. The histidine was identiﬁed in the highly
ariable CDR on the heavy chain. Several operating parameters,
uch as pH, temperature, residence time, and salt concentration
f the feed, play a key role on the extent of the double-peak pat-
ern. This double-peak pattern was seen on multiple CEX resins.
epending on the CEX resins’ separation capacities, mAb  A could
how double-peak or peak-shouldering or a major peak. Therefore,
his issue can be avoided by resin screening.
Although the double-peak pattern was observed on an IgG4, the
ouble-peak pattern could occur on any IgG isotype containing
 similar histidine residue. It is not uncommon to have a histi-
ine residue in CDRs for a mAb. Therefore, these ﬁndings can be
everaged to aid development of other mAbs and predict the like-
ihood of a similar double-peak pattern for a new molecule. This
ork contains useful information to guide protein engineering for
etter design of the molecules to avoid histidine causing double-
eak pattern. The understanding is also valuable for assessing the
mplication of the observed phenomena on product quality and for
ptimization of the puriﬁcation process.
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